Cancer and Blood Diseases

The Monash Partners Comprehensive Cancer Consortium (MPCCC) is the Cancer and Blood Diseases Theme. MPCCC is a strategic alliance of health service and research organisations working in partnership to improve outcomes for people affected by cancer. Our partners work collaboratively to bring a coordinated, multidisciplinary approach to innovating clinical oncology practices, improving cancer services and delivering the next generation of research for better cancer prevention, early detection and treatment of cancer.

Our goal is to improve patient experience and outcomes across the cancer care continuum, through world-class research and quality improvement.

This ambition will be realised by linking our expertise across basic translational, clinical, health service, population health and epidemiological research with the service delivery expertise of our clinical partners.

You can find out more about Monash Partners Comprehensive Cancer Consortium work here or follow MPCCC on Twitter and LinkedIn .

News and Resources

From the Executive Director: Innovation on the international scene Over the past few months, I have had the privilege of taking a sabbatical in the UK, Europe and North… more
New tech helps people with aphasia write their own story Students from the Monash Institute of Medical Engineering (MIME) and Monash Young Medtech Innovators (MYMI) have teamed up with Monash… more
From the Executive Director: Health data alone does not result in healthcare improvement Health data alone does not result in change. An integrated approach is needed for data to inform and enable implementation… more
MIME sponsors winner in Women Leading Tech award Congratulations to Dr Faezeh Marzbanrad, from the Department of Electrical and Computer Systems Engineering and head of the Biomedical Signal Processing… more

View all News & Resources